BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30066757)

  • 1. Prevalence and reactivity of anti-melanoma differentiation-associated gene 5 (anti-MDA-5) autoantibody in Brazilian patients with dermatomyositis.
    Borges IBP; Silva MG; Shinjo SK
    An Bras Dermatol; 2018; 93(4):517-523. PubMed ID: 30066757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis.
    Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R
    Arthritis Care Res (Hoboken); 2016 May; 68(5):689-94. PubMed ID: 26414240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of anti-melanoma differentiation-associated gene 5 antibody in Hong Kong Chinese patients with idiopathic inflammatory myopathies: diagnostic utility and clinical correlations.
    So H; Ip RW; Wong VT; Yip RM
    Int J Rheum Dis; 2018 May; 21(5):1076-1081. PubMed ID: 29380533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan.
    Muro Y; Sugiura K; Hoshino K; Akiyama M; Tamakoshi K
    Arthritis Res Ther; 2011; 13(6):R214. PubMed ID: 22192091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Autoantibody Phenotype and Cutaneous Adverse Reactions to Hydroxychloroquine in Dermatomyositis.
    Wolstencroft PW; Casciola-Rosen L; Fiorentino DF
    JAMA Dermatol; 2018 Oct; 154(10):1199-1203. PubMed ID: 30140893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double anti-PL-7 and anti-MDA-5 positive Amyopathic Dermatomyositis with rapidly progressive interstitial lung disease in a Hispanic patient.
    Li ZY; Gill E; Mo F; Reyes C
    BMC Pulm Med; 2020 Aug; 20(1):220. PubMed ID: 32799827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapidly progressive anti-melanoma differentiation-associated protein 5 (MDA-5)-positive dermatomyositis.
    Kent RA; Venkatesh KP; Radfar A; DeKlotz CMC
    Rheumatology (Oxford); 2020 Jun; 59(6):1461. PubMed ID: 31665465
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosis and treatment of clinically amyopathic dermatomyositis (CADM): a case series and literature review.
    Gil B; Merav L; Pnina L; Chagai G
    Clin Rheumatol; 2016 Aug; 35(8):2125-2130. PubMed ID: 25846833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum.
    Hall JC; Casciola-Rosen L; Samedy LA; Werner J; Owoyemi K; Danoff SK; Christopher-Stine L
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1307-15. PubMed ID: 23436757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-MDA-5 negative, anti-Ku positive clinically amyopathic dermatomyositis.
    Carrington AE; Tartar DM; Sivamani RK
    Dermatol Online J; 2021 Apr; 27(4):. PubMed ID: 33999578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique characteristics of anti-MDA-5 associated dermatomyositis in Southern California with a large Hispanic population.
    Alhassan E; Yi BY; Rodman J; Weisman MH; Crew A; Wise L
    Semin Arthritis Rheum; 2024 Jun; 66():152434. PubMed ID: 38503149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
    Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
    Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and histopathological features of adult patients with dermatomyositis and melanoma differentiation associated-5 autoantibody seropositivity status, as determined by commercially available testing: a retrospective, single-institution comparative cohort study.
    Shakshouk H; Deschaine MA; Wetter DA; Drage LA; Ernste FC; Lehman JS
    Clin Exp Dermatol; 2022 Feb; 47(2):282-288. PubMed ID: 34342883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies.
    Sato S; Murakami A; Kuwajima A; Takehara K; Mimori T; Kawakami A; Mishima M; Suda T; Seishima M; Fujimoto M; Kuwana M
    PLoS One; 2016; 11(4):e0154285. PubMed ID: 27115353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody.
    Takada T; Ohashi K; Hayashi M; Asakawa K; Sakagami T; Kikuchi T; Sato S
    Respir Med; 2018 Aug; 141():7-13. PubMed ID: 30053975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody.
    Cao H; Pan M; Kang Y; Xia Q; Li X; Zhao X; Shi R; Lou J; Zhou M; Kuwana M; Ding X; Zheng J
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1602-10. PubMed ID: 22623119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A severe anti MDA-5 antibodies associated amyopathic dermatomyositis.
    El Euch M; Bani W; Mahfoudhi M; Jaziri F; Ben Abdelghani K; Turki S; Ben Abdallah T
    Tunis Med; 2017 Jun; 95(6):444-445. PubMed ID: 29512806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel dermato-pulmonary syndrome associated with MDA-5 antibodies: report of 2 cases and review of the literature.
    Chaisson NF; Paik J; Orbai AM; Casciola-Rosen L; Fiorentino D; Danoff S; Rosen A
    Medicine (Baltimore); 2012 Jul; 91(4):220-228. PubMed ID: 22732950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis.
    Ceribelli A; Fredi M; Taraborelli M; Cavazzana I; Tincani A; Selmi C; Chan JY; Chan EK; Satoh M; Franceschini F
    Clin Exp Rheumatol; 2014; 32(6):891-7. PubMed ID: 25151986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil extracellular traps may contribute to interstitial lung disease associated with anti-MDA5 autoantibody positive dermatomyositis.
    Peng Y; Zhang S; Zhao Y; Liu Y; Yan B
    Clin Rheumatol; 2018 Jan; 37(1):107-115. PubMed ID: 28842784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.